Vasilopoulou, F.; Bagan, A.; Rodriguez-Arevalo, S.; Escolano, C.; Griñán-Ferré, C.; Pallà s, M.
Amelioration of BPSD-Like Phenotype and Cognitive Decline in SAMP8 Mice Model Accompanied by Molecular Changes after Treatment with I2-Imidazoline Receptor Ligand MCR5. Pharmaceutics 2020, 12, 475.
https://doi.org/10.3390/pharmaceutics12050475
AMA Style
Vasilopoulou F, Bagan A, Rodriguez-Arevalo S, Escolano C, Griñán-Ferré C, Pallàs M.
Amelioration of BPSD-Like Phenotype and Cognitive Decline in SAMP8 Mice Model Accompanied by Molecular Changes after Treatment with I2-Imidazoline Receptor Ligand MCR5. Pharmaceutics. 2020; 12(5):475.
https://doi.org/10.3390/pharmaceutics12050475
Chicago/Turabian Style
Vasilopoulou, Foteini, Andrea Bagan, Sergio Rodriguez-Arevalo, Carmen Escolano, Christian Griñán-Ferré, and Mercè Pallà s.
2020. "Amelioration of BPSD-Like Phenotype and Cognitive Decline in SAMP8 Mice Model Accompanied by Molecular Changes after Treatment with I2-Imidazoline Receptor Ligand MCR5" Pharmaceutics 12, no. 5: 475.
https://doi.org/10.3390/pharmaceutics12050475
APA Style
Vasilopoulou, F., Bagan, A., Rodriguez-Arevalo, S., Escolano, C., Griñán-Ferré, C., & Pallà s, M.
(2020). Amelioration of BPSD-Like Phenotype and Cognitive Decline in SAMP8 Mice Model Accompanied by Molecular Changes after Treatment with I2-Imidazoline Receptor Ligand MCR5. Pharmaceutics, 12(5), 475.
https://doi.org/10.3390/pharmaceutics12050475